Data from literature also support a direct role for Src kinase in modulating mTORC1 activity in several types of cancers (Vojtěchová et al, 2008; Pal et al, 2018), raising the question whether the constitutive activity of Src may trigger the aberrant activation of mTORC1 in GBM. The gene discussed is SRC; the disease is cancer.